CMRX
Price:
$8.54
Market Cap:
$801.08M
Chimerix, Inc. operates as a biopharmaceutical company, committed to advancing therapeutic solutions that improve the lives of individuals grappling with severe medical conditions. Its sole approved medicine is TEMBEXA (brincidofovir), a lipid conjugate designed to combat smallpox by inhibiting viral DNA synthesis, positioned as a critical medical countermeasure. Beyond its commercial offering, Chimerix boasts a robust clinical-stage pipeline: ONC201 targets recurrent diffuse midline glioma in patients whose tumors possess the H3 K27M mutation. ONC206, an imipridone, is a Phase I candidate for solid tumors, functioning as both a Dopamine Receptor D2 (DRD2) antagonist and a caseinolytic prote...[Read more]
Industry
Biotechnology
IPO Date
2013-04-11
Stock Exchange
NASDAQ
Ticker
CMRX
According to Chimerix, Inc.’s latest financial reports and current stock price. The company's current ROE is -56.17%. This represents a change of 264.92% compared to the average of -15.39% of the last 4 quarters.
The mean historical ROE of Chimerix, Inc. over the last ten years is -77.20%. The current -56.17% ROE has changed -27.24% with respect to the historical average. Over the past ten years (40 quarters), CMRX's ROE was at its highest in in the September 2022 quarter at 88.10%. The ROE was at its lowest in in the June 2022 quarter at -84.11%.
Average
-77.20%
Median
-40.82%
Minimum
-374.78%
Maximum
67.03%
Discovering the peaks and valleys of Chimerix, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 552.80%
Maximum Annual ROE = 67.03%
Minimum Annual Increase = -163.45%
Minimum Annual ROE = -374.78%
| Year | ROE | Change |
|---|---|---|
| 2024 | -72.64% | 70.80% |
| 2023 | -42.53% | -163.45% |
| 2022 | 67.03% | -117.88% |
| 2021 | -374.78% | 552.80% |
| 2020 | -57.41% | -63.65% |
| 2019 | -157.93% | 303.74% |
| 2018 | -39.12% | 22.23% |
| 2017 | -32.00% | 15.72% |
| 2016 | -27.66% | -20.96% |
| 2015 | -34.99% | 62.01% |
The current ROE of Chimerix, Inc. (CMRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-16.05%
5-year avg
-96.07%
10-year avg
-77.20%
Chimerix, Inc.’s ROE is greater than Avid Bioservices, Inc. (-112.44%), greater than Icosavax, Inc. (-35.64%), greater than Intercept Pharmaceuticals, Inc. (-253.45%), less than ASLAN Pharmaceuticals Limited (1.80%), greater than Harpoon Therapeutics, Inc. (-211.56%), greater than Albireo Pharma, Inc. (-84.83%), greater than Ikena Oncology, Inc. (-35.20%), greater than Poseida Therapeutics, Inc. (-84.75%), greater than Gracell Biotechnologies Inc. (-37.93%), greater than Verve Therapeutics, Inc. (-16.77%),
| Company | ROE | Market cap |
|---|---|---|
| -112.44% | $798.90M | |
| -35.64% | $769.04M | |
| -253.45% | $794.69M | |
| 1.80% | $777.12M | |
| -211.56% | $865.08M | |
| -84.83% | $915.89M | |
| -35.20% | $718.82M | |
| -84.75% | $925.93M | |
| -37.93% | $197.97M | |
| -16.77% | $994.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chimerix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chimerix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Chimerix, Inc.'s ROE?
How is the ROE calculated for Chimerix, Inc. (CMRX)?
What is the highest ROE for Chimerix, Inc. (CMRX)?
What is the 3-year average ROE for Chimerix, Inc. (CMRX)?
What is the 5-year average ROE for Chimerix, Inc. (CMRX)?
How does the current ROE for Chimerix, Inc. (CMRX) compare to its historical average?